APIs and intermediates

In addition to its APIs and intermediates business, which focuses on generics in focus areas such as lifestyle diseases (hypertension and hyperlipidemia drugs), psychiatric and neurological diseases (antidepressants, antipsychotics, antiepileptics), eye drops, Tokuyama is also working on developing original and novel processes to produce high-purity, economically viable pharmaceutical ingredients.

Special characteristics

• At our Kashima Factory, we produce high-quality products based on facilities and management practices that are compliant with GMP standards.
• Tokuyama has developed a wide variety of technologies for organic synthesis, crystallization, high purification and analysis.